{"title":"Signifikant längeres Überleben mit Bortezomib in der Primärtherapie und im Rezidiv - Neudefinitionen von Behandlungsendpunkten","authors":"","doi":"10.1055/s-0030-1254861","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":123656,"journal":{"name":"Tumordiagn u Ther","volume":"33 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2010-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tumordiagn u Ther","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/s-0030-1254861","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
